FULC
Price
$5.43
Change
+$0.02 (+0.37%)
Updated
May 9, 01:45 PM (EDT)
Capitalization
292.03M
89 days until earnings call
NKTX
Price
$1.95
Change
+$0.08 (+4.28%)
Updated
May 8 closing price
Capitalization
138.37M
90 days until earnings call
Ad is loading...

FULC vs NKTX

Header iconFULC vs NKTX Comparison
Open Charts FULC vs NKTXBanner chart's image
Fulcrum Therapeutics
Price$5.43
Change+$0.02 (+0.37%)
Volume$1K
Capitalization292.03M
Nkarta
Price$1.95
Change+$0.08 (+4.28%)
Volume$461.31K
Capitalization138.37M
FULC vs NKTX Comparison Chart
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. NKTX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a StrongBuy and NKTX is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (FULC: $5.41 vs. NKTX: $1.95)
Brand notoriety: FULC and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 83% vs. NKTX: 30%
Market capitalization -- FULC: $292.03M vs. NKTX: $138.37M
FULC [@Biotechnology] is valued at $292.03M. NKTX’s [@Biotechnology] market capitalization is $138.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than NKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 6 TA indicator(s) are bullish while NKTX’s TA Score has 4 bullish TA indicator(s).

  • FULC’s TA Score: 6 bullish, 4 bearish.
  • NKTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, FULC is a better buy in the short-term than NKTX.

Price Growth

FULC (@Biotechnology) experienced а +23.52% price change this week, while NKTX (@Biotechnology) price change was -4.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.07%. For the same industry, the average monthly price growth was +11.11%, and the average quarterly price growth was -13.36%.

Reported Earning Dates

FULC is expected to report earnings on Aug 06, 2025.

NKTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-5.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($292M) has a higher market cap than NKTX($138M). FULC YTD gains are higher at: 15.106 vs. NKTX (-21.687). FULC has higher annual earnings (EBITDA): -18.24M vs. NKTX (-119.34M). NKTX has more cash in the bank: 283M vs. FULC (241M). FULC has less debt than NKTX: FULC (8.63M) vs NKTX (85.4M). FULC has higher revenues than NKTX: FULC (80M) vs NKTX (0).
FULCNKTXFULC / NKTX
Capitalization292M138M212%
EBITDA-18.24M-119.34M15%
Gain YTD15.106-21.687-70%
P/E RatioN/AN/A-
Revenue80M0-
Total Cash241M283M85%
Total Debt8.63M85.4M10%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCNKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Ad is loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEMYX15.32N/A
N/A
Putnam Emerging Markets Equity Y
CGAEX10.77N/A
N/A
Calvert Global Energy Solutions A
INTIX12.50N/A
N/A
Voya International Index Port S
HMDYX32.48N/A
N/A
Hartford MidCap Y
RYCRX31.78N/A
N/A
Rydex Real Estate C

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with SLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+6.71%
SLS - FULC
48%
Loosely correlated
-1.75%
ANNX - FULC
40%
Loosely correlated
+0.59%
VRDN - FULC
39%
Loosely correlated
+3.99%
NKTX - FULC
36%
Loosely correlated
+4.28%
MLTX - FULC
34%
Loosely correlated
+5.69%
More